Related Experiment Video

Updated: Nov 29, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K

Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia

Chiara Schimmenti1, Vincenzo Sucato2, Elvira Manzone1

  • 1Department of Biological, Chemical and Pharmaceutical Science and Technologies.

Coronary Artery Disease
|November 24, 2020
PubMed

Insights

Bempedoic acid offers a new option for lowering LDL cholesterol, especially when statins are insufficient or not tolerated. It shows promise in combination therapies and for patients with familial hypercholesterolemia.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statin therapy is standard for lowering LDL cholesterol in cardiovascular disease.
  • Statin monotherapy presents challenges including myopathy and inadequate cholesterol reduction in some individuals.
  • There is a clinical need for novel, well-tolerated LDL-lowering therapies.

Purpose of the Study:

  • To review the role of bempedoic acid in lipid-lowering.
  • To evaluate bempedoic acid in combination with statins and other lipid-lowering agents.
  • To assess bempedoic acid as an alternative for patients with heterozygous familial hypercholesterolemia.

Main Methods:

  • Literature review of studies on bempedoic acid.
  • Analysis of clinical trial data for bempedoic acid efficacy and tolerability.
  • Examination of bempedoic acid's mechanism of action and place in therapy.

Main Results:

  • Bempedoic acid effectively lowers LDL cholesterol.
  • Combination therapy with bempedoic acid and statins enhances LDL-C reduction.
  • Bempedoic acid is a well-tolerated option, particularly for statin-intolerant patients.

Conclusions:

  • Bempedoic acid represents a significant advancement in LDL cholesterol management.
  • Its combination use expands therapeutic options for cardiovascular disease prevention.
  • Bempedoic acid is a valuable alternative for specific patient populations, including those with heterozygous familial hypercholesterolemia.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.5K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

59

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
197
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
94
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
374
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
622
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
139